This guide helps pharmaceutical firms navigate complex Middle East and GCC regulatory affairs, covering local requirements, dossier prep, authority liaison, pharmacovigilance, and Arabic labeling for smoother market entry.
Regulatory Affairs in the Middle East and GCC: A Complete Guide for Pharmaceutical Firms Read More »
PharmaOasis guides pharmaceutical firms through complex Middle East and GCC regulatory affairs, offering tailored strategies, dossier management, and compliance expertise for seamless market entry and ongoing safety.
Your Gateway to Middle East and GCC Regulatory Affairs: A Comprehensive Guide Read More »
GCC pharmacovigilance is evolving with digital tools, patient-centric focus, and strict compliance to SFDA GVP and UAE MoHAP guidelines, enhancing drug safety, risk management, and market access.
Innovative Pharmacovigilance in the GCC: Digital, Patient-Centric, Compliant Read More »
Pharmacovigilance is vital for patient safety and market success in the Middle East and GCC, ensuring compliance with SFDA, EDA, MOHAP. Robust systems, local expertise, and proactive risk management sustain market authorization and trust.
Guide details regulatory pathways for pharma, biotech, and MedTech in KSA, UAE, and Egypt, highlighting PharmaOasis Germans EG’s centralized support for registration, compliance, and market access.
Strategic consultation in regulatory affairs helps de-risk pharma launches in the Middle East and GCC by streamlining Saudi FDA and Egypt Drug Authority approvals, ensuring compliance, optimizing pricing, tender access, pharmacovigilance, and lifecycle management.
This guide explains GCC licensing, manufacturing, and compliance requirements, highlighting SFDA/MOHAP registration, Saudi GMP standards, and ISO 13485 for smoother market entry and regulatory success.
Best practices for medical device lifecycle management in the Middle East and GCC include understanding country-specific regulations, implementing ISO 13485 QMS, ensuring Arabic labeling, post-market vigilance, and securing licensed distributors for smooth market access.
This blueprint guides building compliant pharmacovigilance systems in the Middle East/GCC by navigating regional regulations, establishing robust QMS, validating safety databases, and ensuring operational excellence in safety reporting.
PharmaOasis Germans EG offers expert pharmacovigilance support in the Middle East and GCC, ensuring compliance with SFDA and EDA regulations through local expertise, robust risk management, and digital intelligence.
